跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 92 条关于
“Rezera”
全部
92
临床试验
56
药物
9
机构
10
资讯
17
9天前
Rezera's Oral NLRP3 Inhibitor Ruvonoflast Hits Primary Inflammation Endpoint in Phase 2 RESOLVE-1, Phase 3 PAD Trial Planned for 2027
去年
REMORA Trial: Integrating Symptom Tracking App into Rheumatoid Arthritis Care
去年
Reverb Therapeutics Secures $12M Seed Funding to Advance Novel Cytokine-Targeting Platform
2个月前
Fondazione Telethon to Lead €30 Million ERDERA Call for Rare Disease Clinical Trials
11个月前
Medera Strengthens Leadership Team with Three Key Executive Appointments to Advance Cardiac Gene Therapy Pipeline
5个月前
Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy
去年
Hedera Dx Secures €15 Million Series A to Expand Decentralized Liquid Biopsy Platform Across Europe
去年
Medera Showcases Human Mini-Heart Technology Breakthroughs at ISSCR 2025, Advancing Gene Therapy Clinical Trials
去年
Medera Treats First Patient in Groundbreaking Gene Therapy Trial for Duchenne Muscular Dystrophy Heart Failure
去年
Medera's SRD-002 Gene Therapy Advances in Phase 1/2a Trial for HFpEF
第 1 页,共 2 页
上一页
下一页